18-9522420-A-G
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The ENST00000383432.8(RALBP1):āc.964A>Gā(p.Ile322Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000161 in 1,614,214 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
ENST00000383432.8 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RALBP1 | NM_006788.4 | c.964A>G | p.Ile322Val | missense_variant | 4/10 | ENST00000383432.8 | NP_006779.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RALBP1 | ENST00000383432.8 | c.964A>G | p.Ile322Val | missense_variant | 4/10 | 1 | NM_006788.4 | ENSP00000372924.3 | ||
RALBP1 | ENST00000019317.8 | c.964A>G | p.Ile322Val | missense_variant | 4/10 | 1 | ENSP00000019317.4 |
Frequencies
GnomAD3 genomes AF: 0.000112 AC: 17AN: 152234Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000219 AC: 55AN: 250580Hom.: 0 AF XY: 0.000280 AC XY: 38AN XY: 135570
GnomAD4 exome AF: 0.000166 AC: 243AN: 1461862Hom.: 2 Cov.: 31 AF XY: 0.000201 AC XY: 146AN XY: 727234
GnomAD4 genome AF: 0.000112 AC: 17AN: 152352Hom.: 0 Cov.: 33 AF XY: 0.0000940 AC XY: 7AN XY: 74504
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 08, 2022 | The c.964A>G (p.I322V) alteration is located in exon 4 (coding exon 3) of the RALBP1 gene. This alteration results from a A to G substitution at nucleotide position 964, causing the isoleucine (I) at amino acid position 322 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at